MIRA INFORM REPORT

Report Date :

26.04.2011

IDENTIFICATION DETAILS

Name :	INTERNATIONAL DRUG COMPANY LTD

Registered Office :	Plot 2419 Freedom Way Road

Country :	Zambia

Date of Incorporation :	14.03.1978

Legal Form :	Limited Corporation

Line of Business :	manufacture and distribution of pharmaceutical products and medicinal drugs

RATING & COMMENTS

MIRA’s Rating :

RATING		STATUS	PROPOSED CREDIT LINE
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory

Maximum Credit Limit :	USD 80,000

Status :	Satisfactory

Payment Behaviour :	Regular

Litigation :	Clear

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List – December 31, 2010

Country Name

Previous Rating

(30.09.2010)

Current Rating

(31.12.2010)

Zambia

Risk Category	ECGC Classification
Insignificant	A1
Low	A2
Moderate	B1
High	B2
Very High	C1
Restricted	C2
Off-credit	D

SUBJECT'S NAME

Registered Name: INTERNATIONAL DRUG COMPANY LTD

Requested Name: INTERNATIONAL DRUG COMPANY LTD

Other Names: IDC

ADDRESS AND TELECOMMUNICATION

Physical Address: Plot 2419 Freedom Way Road

Postal Address: P.o. Box 31343, Freedom Way Road

Lusaka

Country: Zambia

Phone: 260-211234485/ 6

Fax: 260-211232422/ 223632

Email: None

Website: None

CREDIT OPINION

Financial Index as of December 2010 shows subject firm with a medium risk of credit. However, bank and credit information obtained reveal a history of prompt payments. We recommend Credit of USD 80,000 on 90 days.

LEGAL

Legal Form: Limited Corporation

Date Incorporated: 14/03/1978

Reg. Number: Lusaka, Zambia

Nominal Capital ZMK. 50,000,000

Subscribed Capital ZMK. 50,000,000

Subscribed Capital is Subscribed in the following form:

Position Shares

M Vikram Director

Helen Johnson Administrator

RELATED COMPANIES

None Parent company.

None Subsidiary company.

None Affiliated company.

None Shareholder of subject firm.

Kabwe in Zambia Branches of the firm

OPERATIONS

Registered to operate manufacture and distribution of pharmaceutical products and medicinal drugs

Imports: Asia, Middle East

Exports: None

Trademarks: None

Terms of sale: Cash (40%) and 30 days (60%), invoices.

Main Customers: Governmental and private hospital, clinic and health centers

Employees: 30 employees.

Vehicles: Several motor vehicles.

Territory of sales: Zambia

Location: Rented premises, 5.000 square feet,

AUDITORS AND INSURANCE

Auditors: Information not available.

Insurance Brokers: Information not available.

FINANCE

Currency Reported: Zambian Kwacha (ZMK.)

Approx. Ex. Rate: 1 US Dollar = 4710.22 Zambian Kwacha

Fiscal Year End: December 31, 2010

Inflation: According to information given by independent sources, the inflation at December 31st, 2010 was of 13%.

Financial Information not Submitted

Profit and Loss (expressed in ZMK.)

2010

Sales 17,450,000,000

BANK

Bank Name: EXIM Bank

Comments: None

TRADE REFERENCES

Experiences: Good

NOTARIAL BONDS

None

COMMENTS / ADDITIONAL INFORMATION

This information was obtained from outside sources other than the subject company itself and confirmed the above subject.

FOREIGN EXCHANGE RATES

Currency	Unit	Indian Rupees
US Dollar	1	Rs.44.45
UK Pound	1	Rs.73.35
Euro	1	Rs.64.78

RATING EXPLANATIONS

RATING		STATUS	PROPOSED CREDIT LINE
>86	Aaa	Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums	Unlimited
71-85	Aa	Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums	Large
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small
11-25	Ca	Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity	Limited with full security
<10	C	Absolute credit risk exists. Caution needed to be exercised	Credit not recommended
----	NB	New Business	----

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

Financial condition (40%) Ownership background (20%) Payment record (10%)

Credit history (10%) Market trend (10%) Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.